Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.68M Sell
13,971
-56
-0.4% -$6.46K 0.34% 50
2025
Q4
$1.48M Buy
14,027
+55
+0.4% +$5.16K 0.29% 54
2025
Q3
$1.17M Buy
13,972
+9
+0.1% +$741 0.25% 53
2025
Q2
$1.11M Sell
13,963
-22
-0.2% -$1.75K 0.26% 48
2025
Q1
$1.26M Sell
13,985
-492
-3% -$45.9K 0.33% 45
2024
Q4
$1.44M Buy
14,477
+42
+0.3% +$4.33K 0.36% 42
2024
Q3
$1.64M Buy
14,435
+507
+4% +$60.2K 0.42% 40
2024
Q2
$1.72M Buy
13,928
+276
+2% +$35.6K 0.48% 34
2024
Q1
$1.8M Buy
13,652
+4
+0% +$493 0.52% 34
2023
Q4
$1.49M Sell
13,648
-449
-3% -$46.6K 0.5% 34
2023
Q3
$1.45M Sell
14,097
-3,496
-20% -$377K 0.59% 31
2023
Q2
$1.87M Hold
17,593
0.75% 28
2023
Q1
$1.87M Buy
17,593
+231
+1% +$24.9K 0.75% 28
2022
Q4
$1.93M Hold
17,362
0.87% 27
2022
Q3
$1.5M Buy
17,362
+2,974
+21% +$265K 0.69% 28
2022
Q2
$1.31M Buy
14,388
+167
+1% +$14.8K 0.65% 26
2022
Q1
$1.17M Buy
14,221
+572
+4% +$45.1K 0.5% 27
2021
Q4
$1.05M Buy
13,649
+676
+5% +$53.8K 0.47% 27
2021
Q3
$974K Buy
12,973
+10
+0.1% +$761 0.44% 28
2021
Q2
$1.01M Sell
12,963
-947
-7% -$70.4K 0.46% 28
2021
Q1
$1.02M Sell
13,910
-58
-0.4% -$4.28K 0.63% 28
2020
Q4
$1.09M Buy
13,968
+734
+6% +$56.1K 0.72% 24
2020
Q3
$1.05M Buy
13,234
+38
+0.3% +$2.98K 0.81% 22
2020
Q2
$974K Sell
13,196
-4,226
-24% -$318K 0.81% 22
2020
Q1
$1.28M Buy
+17,422
New +$1.37M 1.17% 22

Other funds holding MRK

Auxano Advisors's MRK Position: Q1 2026 in Review

Auxano Advisors reduced its Merck (MRK) stake by 0.4% in Q1 2026, selling an estimated $6.46K and leaving 13,971 shares worth $1.68M. The position accounts for 0.34% of the portfolio, ranked #50.

Auxano Advisors first reported a position in MRK in Q1 2020 and has held it in 25 quarters since. The position peaked at $1.93M in Q4 2022. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Auxano Advisors held 13,971 shares of Merck worth $1.68M as of Q1 2026.
  • Auxano Advisors sold 56 Merck shares in Q1 2026, an estimated $6.46K.
  • Merck made up 0.34% of Auxano Advisors's portfolio in Q1 2026, its #50 holding.
  • Auxano Advisors first reported a position in Merck in Q1 2020 and has held it in 25 quarters since.
  • Auxano Advisors's Merck position peaked at $1.93M in Q4 2022.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Auxano Advisors's 13F filing for Q1 2026, filed 4 May 2026.